{"url_path":"/sec/rpid/8-k/2026-05-19/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 **","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-19","source_url":"https://www.sec.gov/Archives/edgar/data/1380106/0001104659-26-063936-index.html","accession_number":"0001104659-26-063936","cik":"0001380106","ticker":"RPID","issuer_name":"RAPID MICRO BIOSYSTEMS, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1380106/0001104659-26-063936-index.html","primary_entity_key":"0001380106","primary_entity_name":"RAPID MICRO BIOSYSTEMS, INC."},"word_count":174,"has_tables":true,"body_markdown":"**Item 9.01**\n**Financial Statements and Exhibits.**\n\n \n\n(d) Exhibits.\n\n \n\nExhibit\n\nNo.\nDescription\n\n[1.1](tm2614922d1_ex1-1.htm)\n[Underwriting Agreement, dated as of May 18, 2026, by and among the Company, TD Securities (USA) LLC and Lake Street Capital Markets LLC, as representatives of the several underwriters named therein.](tm2614922d1_ex1-1.htm)\n\n[4.1](tm2614922d1_ex4-1.htm)\n[Form of Pre-Funded Warrant](tm2614922d1_ex4-1.htm)\n\n[4.2](tm2614922d1_ex4-2.htm)\n[Form of Series A Common Stock Warrant](tm2614922d1_ex4-2.htm)\n\n[4.3](tm2614922d1_ex4-3.htm)\n[Form of Series B Common Stock Warrant](tm2614922d1_ex4-3.htm)\n\n[5.1](tm2614922d1_ex5-1.htm)\n[Opinion of Goodwin Procter LLP](tm2614922d1_ex5-1.htm)\n\n[5.2](tm2614922d1_ex5-2.htm)\n[Opinion of Goodwin Procter LLP](tm2614922d1_ex5-2.htm)\n\n[10.1](tm2614922d1_ex10-1.htm)\n[Securities Purchase Agreement, dated as of May 18, 2026, by and between the Company and the purchasers named therein.](tm2614922d1_ex10-1.htm)\n\n[23.1](tm2614922d1_ex5-1.htm)\n[Consent of Goodwin Procter LLP (included in Exhibit 5.1)](tm2614922d1_ex5-1.htm)\n\n[23.2](tm2614922d1_ex5-2.htm)\n[Consent of Goodwin Procter LLP (included in Exhibit 5.2)](tm2614922d1_ex5-2.htm)\n\n104\nCover Page Interactive Data File (formatted as inline XBRL)\n\n  \n\n \n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant to the requirements of the Securities\nExchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \nRAPID MICRO BIOSYSTEMS, INC.\n\n \n \n\nDate: May 19, 2026\nBy:\n/s/ Sean Wirtjes\n\n \n \nSean Wirtjes\n\n \n \nChief Financial Officer"}